supplier
Merck Sharp & Dohme (MSD)
as a supplier
5 recorded awards from 3 buyers , between 10 Aug 2017 and 23 Jul 2020.
awards won
5
exclusive
0%
0 sole-winner awards
median award
£3.9m
largest
£3.9m
“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.
sells to
| buyer | awards |
|---|---|
| Department of Health and Social Care (DHSC) | 2 |
| The NHS Commissioning Board (operating under the name of NHS England) | 2 |
| NHS England | 1 |
contracts won
| contract | buyer | value | awarded |
|---|---|---|---|
| Supportive Medicines Procurement Exercise - CM EMI 20 1100 shared | Department of Health and Social Care (DHSC) | £3,869,091 | 23 Jul 2020 |
| Supportive Medicines Procurement Exercise - CM EMI 20 1100 shared | Department of Health and Social Care (DHSC) | £3,869,091 | 23 Jul 2020 |
| NHS Framework Agreement for Proprietary Pharmaceuticals - South of England (Tranche A) shared | NHS England | £232,000,000 | 10 Aug 2017 |
| NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche shared | The NHS Commissioning Board (operating under the name of NHS England) | · | 2 Mar 2021 |
| NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. shared | The NHS Commissioning Board (operating under the name of NHS England) | · | 23 Feb 2021 |